I took it upon myself to mix it up with John Mack at the Pharma Marketing Blogs. I got the “John Mack treatment.” I like John’s attitude and attentiveness to the pharma world. My diatribes and appearances are here and here. Read the comments. Nothing here about GoodReprintPractices.com. Just some regulatory discussion.
JM (John Murray not John Mack)
The Next Post: While you eagerly await our detailed analyses of GRP Guidance document…
The Previous Post: Mike Misocky Inaugural Post with a Technical and Literary Flourish “Why FDA did what they did”
Comments Down Here
// I Accept Wit, Insight, Disagreement, and American Express.
Sorry, comments for this entry are closed at this time.
You can follow any responses to this entry via its RSS comments feed.
Responses are currently closed, but you can trackback from your own site.